[1] |
Bárbara M, John H, Carmen J, et al. The disruption of protein-protein interactions as atherapeutic strategy for prostate cancer[J]. Pharmacological Res, 2020, 161: 105145.doi: 10.1016/j.phrs.2020.105145.
|
[2] |
Siegel RL, Miller KD, Ahmedin J. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69: 7-34.
|
[3] |
Paul S, Sylvie C, Igor L, et al.Adjuvantradiotherapy versus early salvageradiotherapy plus short-term androgen depriva-tion therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU17): a randomised, phase 3 trial[J]. Lancet Oncol,2020, 21: 1341-1352.
|
[4] |
Morad SA,Schmid M,Buchele B, et al. A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cells[J].Mol Pharmacol, 2013, 83:531-541.
|
[5] |
Liu ML,Sun D,Li T,et al. A systematic review of the immune-regulating and anticancer activities of pseudolaric acid B[J]. Front Pharmacol,2017, 8:394.doi: 10.3389/fphar.2017.00394.
|
[6] |
Jaradat MS,Noonan DJ,Wu BG,et al. Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists[J].Planta Med, 2002, 68: 667-671.
|
[7] |
杨蒙生, 李丽, 刘雪峰,等.土荆皮乙酸促进喉癌细胞系HEp-2 凋亡[J].基础医学与临床,2020,1:92-96.
|
[8] |
金玲,徐天华,王晓丽. 罗格列酮对乳腺癌4T1细胞迁移侵袭和p38 MAPK 信号通路的影响[J].临床肿瘤学杂志,2019, 8: 700-705.
|
[9] |
Chen D, Ayala GE. Innervating prostate cancer[J].N Engl J Med,2018, 378: 675-677.
|
[10] |
Liu RZ, Choi WS, Jain S, et al. The FABP12/PPARγ pathwaypromotes metastatic transformation by inducing epithelial-to-mesenchymal transition and lipid-derived energy production in prostate cancer cells[J]. Mol Oncol, 2020, 14: 3100-3120.
|
[11] |
Tong J, Yin S, Dong Y, et al. Pseudolaric acid B induces caspase-dependent apoptosis and autophagic cell death in prostate cancer cells[J]. Phytother Res,2013, 27: 885-891.
|
[12] |
Xie L,Wu Y,Fan Z,et al. Astragalus polysaccharide protects human cardiac microvascular endothelial cells from hypoxia/reoxygenation injury: the role of PI3K/AKT,Bax/Bcl-2 and caspase-3[J]. Mol Med Rep,2016,14:904-910.
|
[13] |
Wang LT, Li W, Xiu Y,et al. Pseudolaric acid B attenuates atherosclerosis progression and inflammation by suppressing PPARγ-mediated NF-κB activation[J]. Int Immunopharmacol, 2018, 59: 76-85.
|